FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Cequa Recall

Cequa (cyclosporine ophthalmic solution) 0

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Sep 27, 2023
Recall ID
D-1172-2023
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Cequa starting Sep 7, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1172-2023 on Sep 27, 2023. Reason: Subpotent: Out of Specification result observed for low assay. Status: Terminated.

Why it was recalled

Subpotent: Out of Specification result observed for low assay

Product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Lot numbers, UPCs & expiration codes

Lot# 10026, Lot 10027, Exp. 09/2023.

Where it was sold

Nationwide wide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1172-2023
Classification
Class III
Status
Terminated
Recall initiated
Sep 7, 2023
FDA report date
Sep 27, 2023
Quantity
69,707 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-1172-2023, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
93006
Address
2 Independence Way
Code information
Lot# 10026, Lot 10027, Exp. 09/2023.
Postal code
08540-6620
Report date
Sep 27, 2023
Product type
Drugs
Recall number
D-1172-2023
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
69,707 cartons
Termination date
Feb 13, 2024
Reason for recall
Subpotent: Out of Specification result observed for low assay
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96
Distribution pattern
Nationwide wide in the USA
Recall initiation date
Sep 7, 2023
Initial firm notification
Letter
Center classification date
Sep 20, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1172-2023, published Sep 27, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls